SORICIMED BIOPHARMA INC has a total of 21 patent applications. Its first patent ever was published in 2009. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NO 309 HOSPITAL OF PLA, NVH MEDICINAL and OXYGENIX CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | Hong Kong | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Nanostructure applications | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Stewart John M | 21 |
#2 | Vernes Karl | 4 |
#3 | Steeves Bradley J | 4 |
Publication | Filing date | Title |
---|---|---|
CA3083950A1 | Trpv6 inhibitors and combination therapies for treating cancers | |
MX2012000086A | Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery. | |
US2010305029A1 | Paralytic peptide for use as a insecticide | |
EP2268665A1 | Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |